MAINTENANCE OF LEBRIKIZUMAB EFFICACY IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS WITH STABLE ASTHMA CONTROL

被引：0
|
作者：
Mehta, V.
Worm, M.
Chiesa, Z.
Natalie, C.
Dawson, Z.
Zhong, J.
Diemert, S.
Boguniewicz, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P280
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [1] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Smith, Brandon I.
    Engel, Priya
    Wu, Jashin
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
  • [2] MAINTENANCE OF LEBRIKIZUMAB EFFICACY IN PATIENTS WITH MODERATE -TO -SEVERE ATOPIC DERMATITIS AND ATOPIC COMORBIDITIES
    Sher, E.
    Golant, A.
    DeBruin-Weller, M.
    Dawson, Z.
    Atwater, A.
    Zhong, J.
    Carrascosa, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S9 - S9
  • [3] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Diana Bernardo
    Thomas Bieber
    Tiago Torres
    American Journal of Clinical Dermatology, 2023, 24 : 753 - 764
  • [4] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [5] Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Weidinger, Stephan
    Simpson, Eric
    Gooderham, Melinda
    Irvine, Alan
    Spelman, Lynda
    Silverberg, Jonathan
    Elmaraghy, Hany
    DeLuca-Carter, Louise
    Piruzeli, Maria Lucia Buziqui
    Hu, Chaoran
    Yang, Fan Emily
    Pierce, Evangeline
    Bardolet, Laia
    Thaci, Diamant
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II3 - II4
  • [6] Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis
    Murase, Jenny E.
    Chovatiya, Raj
    Strowd, Lindsay
    Thyssen, Jacob P.
    Bangert, Christine
    Atwater, Amber Reck
    Gallo, Gaia
    Bardolet, Laia
    Yang, Fan
    Zhong, Jinglin
    Staumont-Salle, Delphine
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [7] Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis
    Arents, Bernd W. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (06) : 694 - 694
  • [8] Maintenance of efficacy and safety with lebrikizumab up to one year of treatment in patients with moderate-to-severe atopic dermatitis with or without topical corticosteroids
    Guttman-Yassky, E.
    Weidinger, S.
    Silverberg, J.
    Gooderham, M.
    Thyssen, J.
    Irvine, A.
    Elmaraghy, H.
    Natalie, C.
    Hu, C.
    Pierce, E.
    Gil, E. G.
    Simpson, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S348 - S348
  • [9] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Okragly, Angela
    Sun, Zhe
    Mena, Laura Rebeca
    Hahn, Nathan
    Nickoloff, Brian J.
    Siu, Kimberly
    Gallo, Gaia
    Wolf, Eric
    Eyerich, Kilian
    Aparici, Monica
    Benschop, Robert J.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II4 - II5
  • [10] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L. R.
    Hahn, N.
    Nickoloff, B. J.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S364 - S364
12345